Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Go back to Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 36.38 -0.93 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.31 | 52 Week High | $5.17 | |||
| Open | $36.65 | 52 Week Low | $0.94 | |||
| Day High | $36.81 | P/E | N/A | |||
| Day Low | $35.67 | EPS | $0.00 | |||
| Volume | 1,608,812 | |||||
